Navigation Links
Plastic Surgery Practice Gets Boost from Lower Eyelid Surgery Webinar
Date:1/28/2013

New York (PRWEB) January 28, 2013

Facial Plastic Surgeon Dr. Edwin Williams of the Williams Center in Albany and Manhattan was excited to host his very first webinar on lower eyelid surgery.

For the very first time the Williams Center hosted its own webinar on lower eyelid surgery. Board Certified Facial Plastic Surgeon Dr. Edwin Williams, M.D., described how he accomplished the results seen in the before and after pictures shown to over 50 attendees in a power point presentation. This was followed by a question and answer period. The attendees received a free consultation and $400.00 off their procedure if they scheduled the procedure within 6 weeks of the webinar.

"We were extremely happy with a 20% conversion rate. We used “Go To Meeting” to facilitate the webinar and they generated useful reports which included a list of webinar attendees, e-mail addresses of registered attendees, questions submitted, and even how long each attendee stayed on the webinar! We would recommend them for any business. The key to its success is being prepared with e-mail invites, being able to respond to all inquiries in a timely fashion and to most of all have fun!"

Eyelid surgery, known technically as blepharoplasty, is a facial plastic surgery procedure which corrects aging conditions of the eye area. The surgery may be performed on the upper eyelids, lower eyelids or both. Lower eyelid surgery is a very popular procedure for improving puffy under eye bags. Surgery may be performed with local anesthesia and sedation and typically takes one to two hours to complete. Incisions may be hidden inside of the lower eyelid or along the lower lash line, allowing excess fat and skin to be removed for a younger, more rested appearance.

Dr. Williams is a double board certified facial plastic and reconstructive surgeon and ENT. He has dedicated his practice to surgical and non-surgical procedures of the head, face and neck including rhinoplasty, revision rhinoplasty, brow lift, facial implants, facelift, fat transfer, lip enhancement, ear surgery, laser skin resurfacing, acne scar treatment, scar repair, chemical peel, vascular birthmark treatment, and more. He is actively involved in teaching facial plastic and reconstructive surgery to residents of the Albany Medical Center where he also serves as Clinical Professor in the Department of Surgery.

The Williams Center for Plastic Surgery is dedicated to providing excellence in state-of-the-art cosmetic procedures. Dr. Williams is joined by Dr. Alain Polynice who specializes in plastic surgery of the breasts and body, as well as Dr. Allison Pontius who specializes in facial plastic and reconstructive surgery and anti-aging and regenerative medicine with a particular interest in non-surgical facial rejuvenation. The Williams Center has two locations in Albany, New York, and Manhattan. To contact the Williams Center call (800) 742-2792 or visit us online.

Read the full story at http://www.prweb.com/releases/DrWilliams2013/EyelidSurgeryWebinar/prweb10345891.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Common Plastics Chemical Might Boost Diabetes Risk
2. Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction, Moffitt says
3. Plastics Chemical Linked to Obesity in Kids
4. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
5. Myelodysplastic Syndrome Linked to Abnormal Stem Cells
6. Plastics Chemical in Dental Fillings Might Affect Childrens Behavior: Study
7. A CNIO team creates a unique mouse model for the study of aplastic anaemia
8. Students win $100K for 3-D printer to turn waste plastic into composting toilets, rainwater systems
9. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
10. First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
11. New form of brain plasticity: Study shows how social isolation disrupts myelin production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... 2017 , ... Guide to FDA and EU Medical Device Regulations: 2017 Edition, ... of the Atlantic devicemakers do business, this fully updated and expanded guide keeps them ... to the full text of the FDA’s regulations in 21 CFR Parts 800 to ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold ... President for the Illinois State Bar Association , in accordance with the organization’s rules ... 2016 following a state-wide election and served in that capacity for the past year prior ...
(Date:6/28/2017)... Columbia (PRWEB) , ... June 28, 2017 , ... ... (FSE: ZEON) is pleased to announce that a two year study conducted by ... Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Dianne ... the greater Cincinnati metropolitan area, is teaming up with the local chapter of ... children receiving treatment in nearby hospitals. , Ronald McDonald House of Greater Cincinnati, ...
(Date:6/27/2017)... ... 27, 2017 , ... Harbour , a DAO (decentralized autonomous organization) that ... has released their technical specifications . , 2017 has seen an explosion of ... for determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: